Gastric Ultrasound After Clear Fluid Intake in Diabetic and Non-Diabetic Pregnant Women

June 2, 2026 updated by: Esra Uyar Türkyılmaz, Ankara City Hospital Bilkent

Effect of Preoperative Clear Fluid Intake on Gastric Volume in Diabetic and Non-Diabetic Pregnant Women Assessed by Gastric Ultrasonography

Pulmonary aspiration of gastric contents during anesthesia is a serious perioperative complication associated with significant morbidity and mortality. Pregnant patients are at increased risk of aspiration due to physiological changes such as delayed gastric emptying and increased intra-abdominal pressure. In addition, diabetes may impair gastric motility because of autonomic neuropathy, potentially leading to gastroparesis and increased gastric residual volume.

Current fasting guidelines allow the intake of clear fluids up to two hours before anesthesia. However, the effect of preoperative oral clear fluid intake on gastric volume in diabetic pregnant patients remains unclear.

This prospective observational study aims to compare gastric volume measured by gastric ultrasonography in diabetic and non-diabetic pregnant women undergoing elective cesarean delivery. All participants will receive 200 ml of water two hours before surgery. Gastric ultrasonography will be performed before fluid intake and two hours after intake to evaluate gastric volume and gastric content.

The results of this study may help improve the assessment of aspiration risk and guide perioperative fasting recommendations in pregnant patients, particularly those with diabetes.

Study Overview

Detailed Description

Pulmonary aspiration of gastric contents is one of the most feared complications of obstetric anesthesia and may lead to severe morbidity and mortality. Pregnancy is associated with physiological changes such as delayed gastric emptying, increased intra-abdominal pressure, and gastroesophageal reflux, all of which may increase the risk of aspiration during anesthesia. Diabetes mellitus may further affect gastric motility due to autonomic neuropathy, potentially leading to gastroparesis and increased gastric residual volume.

Preoperative fasting guidelines from major anesthesia societies recommend that patients may consume clear fluids up to two hours before anesthesia. However, the effect of preoperative oral clear fluid intake on gastric volume in diabetic pregnant patients remains controversial.

This single-center prospective observational study will be conducted in pregnant women scheduled for elective cesarean delivery. A total of 70 participants will be included and divided into two groups: diabetic pregnant women and non-diabetic pregnant women. All participants will receive 200 ml of water two hours before surgery according to standard fasting guidelines.

Gastric ultrasonography will be performed before fluid intake and two hours after fluid intake. The gastric antrum will be identified using anatomical landmarks including the left lobe of the liver, pancreas, aorta, and inferior vena cava. Measurements will be obtained in both the semi-recumbent and right lateral decubitus positions.

The gastric antral cross-sectional area will be calculated using the formula:

CSA = (D1 × D2 × π) / 4.

Gastric volume will be estimated using the Roukhomovsky equation. In addition to quantitative measurements, qualitative assessment of gastric contents will be performed using the Perlas grading system.

The primary objective of the study is to compare gastric volume between diabetic and non-diabetic pregnant women after preoperative clear fluid intake. Secondary objectives include qualitative evaluation of gastric contents and assessment of aspiration risk defined as gastric volume greater than 1.5 ml/kg.

Study Type

Observational

Enrollment (Estimated)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Pregnant women aged 18-40 years undergoing elective cesarean section under spinal anesthesia at a tertiary care hospital. The study includes both diabetic and non-diabetic pregnant women who meet the eligibility criteria and provide informed consent.

Description

Inclusion Criteria:

  • Pregnant women aged 18-40 years
  • Scheduled for elective cesarean section under spinal anesthesia
  • Singleton pregnancy
  • ASA physical status II
  • Patients who provide written informed consent

Exclusion Criteria:

  • Refusal to participate in the study
  • Contraindication to spinal anesthesia
  • Known allergy to study medications
  • Multiple pregnancy
  • Severe systemic disease (ASA III or higher)
  • Pre-existing neurological disease
  • Infection at the spinal puncture site

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Diabetic Pregnant Women
Pregnant women with diet-controlled diabetes undergoing elective cesarean delivery. Participants will receive 200 ml of water two hours before surgery and gastric ultrasonography will be performed before and after fluid intake.
Non-Diabetic Pregnant Women
Pregnant women without diabetes undergoing elective cesarean delivery. Participants will receive 200 ml of water two hours before surgery and gastric ultrasonography will be performed before and after fluid intake.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gastric Volume Measured by Ultrasonography
Time Frame: Before oral clear fluid intake and two hours after fluid intake before anesthesia
Gastric antral cross-sectional area will be measured using gastric ultrasonography and gastric volume will be calculated using the Roukhomovsky formula. Gastric volume will be compared between diabetic and non-diabetic pregnant women undergoing elective cesarean delivery.
Before oral clear fluid intake and two hours after fluid intake before anesthesia

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Qualitative Assessment of Gastric Contents
Time Frame: Before oral clear fluid intake and two hours after fluid intake
Gastric contents will be qualitatively assessed using the Perlas grading system (Grade 0-2) in both supine and right lateral decubitus positions.
Before oral clear fluid intake and two hours after fluid intake
Aspiration Risk Based on Gastric Volume
Time Frame: Two hours after oral clear fluid intake before anesthesia
Aspiration risk will be assessed using the threshold of gastric volume greater than 1.5 ml/kg.
Two hours after oral clear fluid intake before anesthesia

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Study Registration Dates

First Submitted

March 16, 2026

First Submitted That Met QC Criteria

March 16, 2026

First Posted (Actual)

March 19, 2026

Study Record Updates

Last Update Posted (Actual)

June 4, 2026

Last Update Submitted That Met QC Criteria

June 2, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe